Receptors by developing NK cells derived from embryonic stem cells in

Receptors by developing NK cells derived from embryonic stem cells in vitro. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/20460822 J Immunol 2002, 168:4980?987. 74. Timmermans F, Velghe I, Vanwalleghem L, De Smedt M, Van Coppernolle S, Taghon T, Moore HD, Leclercq G, Langerak AW, Kerre T, Plum J, Vandekerckhove B: Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J Immunol 2009, 182:6879?888. 75. Carpenter L, Malladi R, Yang CT, French A, Pilkington KJ, Forsey RW, Sloane-Stanley J, Silk KM, Davies TJ, Fairchild PJ, Enver T, Watt SM: Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. Blood 2011, 117:4008?011. 76. Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS: Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. J Virol 2011, 85:43?0. 77. Senju S, Haruta M, Matsunaga Y, Fukushima S, Ikeda T, Takahashi K, Okita K, Yamanaka S, Nishimura Y: Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Methyl 2-((4-nitro-1h-pyrazol-1-yl)methyl)benzoate Stem Cells 2009, 27:1021?031. 78. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA: Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001, 98:10716?0721. 79. Karlsson KR, Cowley S, Martinez FO, Shaw M, Minger SL, James W: Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp Hematol 2008, 36:1167?175. 80. Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH, Wagner EF, Keller GM: Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 2010, 115:2769?776. 81. Era T, TEthyl ijms17122034ijms17122034 (4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbamate hydrochloride ES cell in vitro differentiation induction system. Blood 2000, 95:870?78. 82. Eto K, Murphy R, Kerrigan SW, Bertoni A, Stuhlmann H, Nakano T, Leavitt AD, Shattil SJ: Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci USA 2002, 99:12819?2824. 83. Gaur M, Kamata T, Wang S, Moran B, Shattil SJ, Leavitt AD: Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost 2006, 4:436?42. 84. Kulkeaw K, Horio Y, Mizuochi C, Ogawa M, Sugiyama D: Variation in hematopoietic potential of induced pluripotent stem cell lines. Stem Cell Rev 2010, 6:381?89. 85. Inoue T, Kulkeaw K, Okayama S, Tani K, Sugiyama D: Variation in mesodermal and hematopoietic potential of adult skin-derived induced pluripotent stem cell lines in mice. Stem Cell Rev 2011, 7:958?68. 86. Reimer A, Seiler K, Tornack J, Tsuneto M, Melchers F: Reprogramming to iPS cells and their subsequent hematopoietic differentiation is more efficient from PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/10811056 MEFs than from preB cells. Immunol Lett 2012, 143:70?6. 87. Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH: Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci USA 2012, 109:17567?7572. 88. Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, Hock H, Hochedlinger K: Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009, 41:968?76.doi.